Condition: Solid Organ Transplantation · Bone Marrow Transplantation · Sponsor: University of Pittsburgh
The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.
This description comes directly from the study's public registry record.
Morgan L Paul, BSN · 412-692-8472 · Morgan.Paul2@upmc.edu
Daniel Pieratt, MPA · 412-692-6692 · pierattdw@upmc.edu
Always discuss trial participation with your own doctor first.
| Children's Hospital of Pittsburgh of UPMC | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01163578